Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI. (Q45856327)

17 December 2017

title

Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI. (English)

1 reference

17 December 2017

0 references

Satoshi Shintani

1

1 reference

17 December 2017

Kengo Kusano

2

1 reference

17 December 2017

Masaaki Ii

3

1 reference

17 December 2017

Atsushi Iwakura

4

1 reference

17 December 2017

Lindsay Heyd

5

1 reference

17 December 2017

Cynthia Curry

6

1 reference

17 December 2017

Andrea Wecker

7

1 reference

17 December 2017

Mary Gavin

8

1 reference

17 December 2017

Hong Ma

9

1 reference

17 December 2017

Marianne Kearney

10

1 reference

17 December 2017

Marcy Silver

11

1 reference

17 December 2017

Tina Thorne

12

1 reference

17 December 2017

Toyoaki Murohara

13

1 reference

17 December 2017

Douglas W Losordo

14

1 reference

17 December 2017

publication date

1 March 2006

1 reference

17 December 2017

Nature Clinical Practice Cardiovascular Medicine

published in

1 reference

17 December 2017

volume

3 Suppl 1

1 reference

17 December 2017

page(s)

S123-8

1 reference

17 December 2017

Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

CD34 + and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Mobilization of endothelial progenitor cells in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Circulating endothelial progenitor cells and cardiovascular outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0430

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0430

1 reference

17 December 2017

PubMed ID

16501618

1 reference

17 December 2017